Literature DB >> 3114546

[Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases].

W Mühlberg, D Platt, M Bauer, U Salzner.   

Abstract

The pharmacokinetics of theophylline (200 mg i.v.) were determined in 20 geriatric patients with multiple diseases. Serum concentrations were fitted to an open 2-compartment model. Percent changes in venous pCO2 and pO2 were used as parameters of the pharmacodynamic action. Total clearance was decreased and elimination half-life of theophylline was found to be prolonged in the elderly patients compared with data of a study with young healthy volunteers. The stronger the pharmacodynamic action of theophylline (percent change of venous pCO2 after 30 min), the faster was its elimination and the lower were measured concentrations after 2, 6, and 12 h.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114546     DOI: 10.1007/bf01727621

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.

Authors:  T Uematsu; F Follath; S Vozeh
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Pharmacokinetics of theophylline in ten elderly patients.

Authors:  F Nielsen-Kudsk; I Magnussen; P Jakobsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-03

3.  Rapid assay for theophylline in clinical samples by reversed-phase high-performance liquid chromatography.

Authors:  P J Naish; M Cooke; R E Chambers
Journal:  J Chromatogr       Date:  1979-08-21

4.  Intravenous theophylline therapy: nomogram guidelines.

Authors:  W J Jusko; J R Koup; J W Vance; J J Schentag; P Kuritzky
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

5.  Efficacy of theophylline in "irreversible" airflow obstruction.

Authors:  M L Eaton; B A Green; T R Church; T McGowan; D E Niewoehner
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

6.  Theophylline elimination in congestive heart failure.

Authors:  H D Kuntz; H Straub; B May
Journal:  Klin Wochenschr       Date:  1983-11-02

7.  Theophylline kinetics in relation to age: the importance of smoking.

Authors:  B Cusack; J G Kelly; J Lavan; J Noel; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

8.  Enprofylline: pharmacokinetics and comparison with theophylline of acute effects on bronchial reactivity in normal subjects.

Authors:  T B Kluge; M Oellerich; G Schumann; G W Sybrecht
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Non-linear elimination processes of theophylline.

Authors:  U Gundert-Remy; R Hildebrandt; N Hengen; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Theophylline kinetics in chronic obstructive airway disease in the elderly.

Authors:  W Y Au; A K Dutt; N DeSoyza
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

View more
  3 in total

Review 1.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 2.  Pharmacokinetic changes in patients with oedema.

Authors:  B Vrhovac; N Sarapa; I Bakran; M Huic; V Macolic-Sarinic; I Francetic; A Wolf-Coporda; F Plavsic
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.